January 2023 Issue
Vol 2 Issue 1
- Promising new vaccines and approaches in preclinical development
- Scientific, regulatory, and manufacturing challenges of new and emerging platforms
- Progress toward vaccines for challenging diseases
- Beyond antibody response: harnessing cytotoxic T cells and trained immunity
- New technology and approaches in cancer vaccines
Featuring
Issue Spotlight:
Preclinical research & next-generation vaccine platforms
